United States Biosurgery Market expected to grow at a CAGR of 7.56% during 2024-2031 | Top Companies - Johnson & Johnson, Integra Lifesciences Corporation, Baxter International Inc.

"The Global Biosurgery Market is expected to reach at a CAGR of 7.56% during the forecast period 2024-2031." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/biosurgery-market?sp

United States: Recent Industry Developments

✅ In November 2025, Johnson & Johnson MedTech through its Ethicon division launched a next-generation surgical adhesive under the SURGIFLOTM Hemostatic Matrix line featuring enhanced flow control and reduced preparation time. The product is designed for cardiovascular and orthopedic procedures, ensuring faster bleeding control and tissue sealing. It underscores J&J's continued innovation in minimally invasive biosurgical solutions.

✅ In October 2025, Baxter International Inc. announced FDA clearance for its advanced Hemopatch Sealing Hemostat, developed with collagen and NHS-PEG coating for rapid hemostasis and broad surgical application. The launch strengthens Baxter's position in surgical sealants and hemostatic patches. It reflects the U.S. market's growing reliance on bioengineered materials over traditional sutures.

✅ In September 2025, Integra LifeSciences expanded its production facility in New Jersey to increase output of its DuraSeal® and Tisseel® biosurgery product lines. The move supports rising global demand for absorbable hemostats and sealants used in neuro and spine surgeries. It demonstrates Integra's strategic effort to enhance biosurgery manufacturing resilience.

✅ In August 2025, Becton Dickinson (BD) announced a collaborative R&D project to develop hydrogel-based surgical sealants designed for faster wound healing and reduced postoperative complications. The project leverages BD's expertise in biocompatible polymers for advanced tissue repair. It emphasizes the company's long-term push into regenerative biosurgery materials.

Japan: Recent Industry Developments

✅ In November 2025, Terumo Corporation introduced its Hemostat-PureTM biosurgical patch targeting precise bleeding control in cardiovascular and laparoscopic procedures. The patch uses purified gelatin and oxidized cellulose technology for rapid coagulation. It highlights Terumo's strategy to strengthen its presence in the advanced surgical hemostats segment.

✅ In October 2025, Gunze Limited obtained domestic regulatory approval for its TissueGuardTM absorbable adhesion barrier used in abdominal surgeries. The innovation offers high biocompatibility and reduces postoperative adhesion risk in minimally invasive procedures. It positions Gunze as a leader in Japan's biosurgery and biomaterial innovation landscape.

✅ In September 2025, Kaken Pharmaceutical Co., Ltd. collaborated with leading universities to develop enzymatically cross-linked hydrogel sealants for ophthalmic and microvascular surgeries. The research focuses on reducing inflammation and improving wound integration. It reinforces Japan's biosurgery R&D strength in precision and specialty applications.

✅ In August 2025, Nipro Corporation launched a new fibrin-based biosurgical sealant targeting faster intraoperative hemostasis in organ transplant and trauma cases. The product emphasizes bio-safety and quick absorption, ensuring minimal foreign-body reaction. It supports Japan's commitment to next-generation biopolymer-based surgical solutions.

Biosurgery Market: Drivers

The biosurgery market is growing rapidly as the demand for advanced surgical solutions that promote faster healing, reduce complications, and improve clinical outcomes continues to rise. Biosurgical products-such as hemostatic agents, surgical sealants, adhesion barriers, and soft tissue repair materials-play a crucial role in managing blood loss and enhancing tissue regeneration during complex procedures. The increasing volume of surgeries related to orthopedics, cardiovascular, and neurosurgery is fueling adoption. Moreover, the rising preference for minimally invasive surgeries and bioresorbable materials is driving technological innovation. With hospitals emphasizing shorter recovery times and improved patient outcomes, biosurgery solutions are becoming integral to modern surgical care.

Technological advancements in biomaterials, regenerative medicine, and biotechnology are leading to next-generation biosurgical products with enhanced biocompatibility and performance. The use of collagen, fibrin, and gelatin-based biomaterials is expanding across wound management and reconstructive procedures. Additionally, increasing healthcare expenditure and the growing elderly population with chronic diseases are contributing to market expansion. Manufacturers are focusing on developing combination products that integrate mechanical and biological healing mechanisms for superior efficacy. As surgical practices continue to evolve toward precision, safety, and rapid recovery, the biosurgery market is set for strong, innovation-driven growth in the coming years.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/biosurgery-market?sp

Biosurgery Market: Major Players

Johnson & Johnson, Integra Lifesciences Corporation, Baxter International Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, CryoLife, Inc., Pfizer, Strykers, C.R. Bard and Sanofi.

Segment Covered in the Biosurgery Market:

By Product
The market is segmented into Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, and Bone Graft Attachments. Surgical sealants hold a major share due to their widespread use in preventing fluid leakage and promoting wound closure. Hemostatic agents are gaining demand for their critical role in controlling bleeding during surgeries, while adhesion barriers are increasingly adopted to reduce post-operative complications. Soft tissue and bone graft attachments are also witnessing steady growth with advancements in biomaterials and tissue engineering technologies.

By Application
Based on application, the market is categorized into General Surgery, Orthopedic Surgery, Cardiovascular Surgery, and Neurological Surgery. General surgery accounts for the largest share owing to the high number of procedures utilizing sealants and hemostatic agents. Orthopedic and cardiovascular surgeries are also key segments, driven by the rising incidence of trauma cases and cardiac disorders. Meanwhile, neurological surgery is emerging as a promising area due to increasing applications of bioadhesives in delicate brain and spine operations.

Research Process:

Both primary and secondary data sources have been used in the Biosurgery Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Biosurgery Market Research Industry:

➠ Who leads the Biosurgery industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Biosurgery market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Biosurgery market growth?
➠ What are the dominant sales and distribution strategies in the Biosurgery industry?

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=biosurgery-market
(Purchase 2 or more Repots and get 50% Discount)

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.